Literature DB >> 27993095

Personnel dose reduction in 90Y microspheres liver-directed radioembolization: from interventional radiology suite to patient ward.

Martin Law1, K K Wong1, W K Tso1, Victor Lee2, M Y Luk3, C C Tong3, Ferdinand Chu1.   

Abstract

OBJECTIVE: To describe a method to reduce the external radiation exposure emitted from the patient after liver-directed radioembolization using 90Y glass microspheres, to quantitatively estimate the occupational dose of medical personnel providing patient care to the patient radioembolized with the use of the method and to discuss radiation exposure to patients who are adjacent if the patient radioembolized needs hospitalization.
METHODS: A lead-lined blanket of lead equivalence of 0.5 mm was used to cover the patient abdomen immediately after the 90Y radioembolization procedure, in order to reduce the radiation emitted from the patient. The interventional radiologist used a rod-type puncture site compressor for haemostasis to avoid direct contact with possible residual radioactivity at the puncture site. Dose rates were measured at the interventional radiologist chest and hand positions during puncture site pressing for haemostasis with and without the use of the blanket. The measurement results were applied to estimate the occupational dose of colleagues performing patient care to the patient radioembolized. The exposure to patients adjacent in the ward was estimated if the patient radioembolized was hospitalized.
RESULTS: The radiation exposures measured at the radiologist chest and hand positions have been significantly reduced with the lead-lined blanket in place. The radiologist, performing puncture site pressing at the end of radioembolization procedure, would receive an average hand dose of 1.95 μSv and body dose under his own lead apron of 0.30 μSv for an average 90Y microsphere radioactivity of 2.54 GBq. Other medical personnel, nurses and porters, would receive occupational doses corresponding to an hour of background radiation. If the patient radioembolized using 90Y needs hospitalization in a common ward, using the lead-lined blanket to cover the abdomen of the patient and keeping a distance of 2 m from the patient who is adjacent would reduce the exposure by 0.42% of dose limit for the general public.
CONCLUSION: By placing a lead-lined blanket on the patient abdominal region after 90Y radioembolization, hospital staff receive minimal radiation exposure in order to comply with the radiation protection "as low as reasonably achievable" principle. There will be no increase in radiation level in ward if the patient radioembolized using 90Y needs to be hospitalized. Therefore, the patient radioembolized can be accommodated alternatively at a corner bed of a common ward if an isolation room with private toilet facility is not available. Advances in knowledge: To reduce exposure to personnel providing patient care to patients radioembolized using 90Y.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27993095      PMCID: PMC5601515          DOI: 10.1259/bjr.20160591

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  9 in total

1.  The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103.

Authors: 
Journal:  Ann ICRP       Date:  2007

2.  Yttrium-90 radioembolization is a viable treatment option for unresectable, chemorefractory colorectal cancer liver metastases: further evidence in support of a new treatment paradigm.

Authors:  Ryan Hickey; Robert Lewandowski; Riad Salem
Journal:  Ann Surg Oncol       Date:  2014-10-31       Impact factor: 5.344

3.  Radiation emission from patients treated with selective hepatic radioembolization using yttrium-90 microspheres: are contact restrictions necessary?

Authors:  Jeffrey W McCann; Ann M Larkin; Larry J Martino; David J Eschelman; Carin F Gonsalves; Daniel B Brown
Journal:  J Vasc Interv Radiol       Date:  2012-03-21       Impact factor: 3.464

Review 4.  Yttrium-90 hepatic radioembolization: clinical review and current techniques in interventional radiology and personalized dosimetry.

Authors:  Aaron K T Tong; Yung Hsiang Kao; Chow Wei Too; Kenneth F W Chin; David C E Ng; Pierce K H Chow
Journal:  Br J Radiol       Date:  2016-03-24       Impact factor: 3.039

5.  Image-guided personalized predictive dosimetry by artery-specific SPECT/CT partition modeling for safe and effective 90Y radioembolization.

Authors:  Yung Hsiang Kao; Andrew Eik Hock Tan; Mark Christiaan Burgmans; Farah Gillian Irani; Li Ser Khoo; Richard Hoau Gong Lo; Kiang Hiong Tay; Bien Soo Tan; Pierce Kah Hoe Chow; David Chee Eng Ng; Anthony Soon Whatt Goh
Journal:  J Nucl Med       Date:  2012-02-17       Impact factor: 10.057

Review 6.  Posttherapy radiation safety considerations in radiomicrosphere treatment with 90Y-microspheres.

Authors:  Seza A Gulec; Jeffry A Siegel
Journal:  J Nucl Med       Date:  2007-11-15       Impact factor: 10.057

7.  Radiation safety issues in y-90 microsphere selective hepatic radioembolization therapy: possible radiation exposure from the patients.

Authors:  Young-Chul Kim; Yun-Hwan Kim; Soon-Ho Uhm; Yeon Seok Seo; Eun-Kyung Park; Sun-Young Oh; Eugene Jeong; Sinae Lee; Jae-Gol Choe
Journal:  Nucl Med Mol Imaging       Date:  2010-08-25

Review 8.  Yttrium-90 Selective Internal Radiation Therapy with Glass Microspheres for Hepatocellular Carcinoma: Current and Updated Literature Review.

Authors:  Edward Wolfgang Lee; Lourdes Alanis; Sung-Ki Cho; Sammy Saab
Journal:  Korean J Radiol       Date:  2016-06-27       Impact factor: 3.500

9.  Patient dosimetry for 90Y selective internal radiation treatment based on 90Y PET imaging.

Authors:  Sherry C Ng; Victor H Lee; Martin W Law; Rico K Liu; Vivian W Ma; Wai Kuen Tso; To Wai Leung
Journal:  J Appl Clin Med Phys       Date:  2013-09-06       Impact factor: 2.102

  9 in total
  2 in total

Review 1.  Breast cancer liver metastasis: current and future treatment approaches.

Authors:  Narmeen S Rashid; Jacqueline M Grible; Charles V Clevenger; J Chuck Harrell
Journal:  Clin Exp Metastasis       Date:  2021-03-06       Impact factor: 5.150

Review 2.  Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer Treatment.

Authors:  Hossein Jadvar
Journal:  AJR Am J Roentgenol       Date:  2017-05-02       Impact factor: 3.959

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.